32 related articles for article (PubMed ID: 2455037)
1. Protective effects of a polysaccharide from Spirulina platensis on dopaminergic neurons in an MPTP-induced Parkinson's disease model in C57BL/6J mice.
Zhang F; Lu J; Zhang JG; Xie JX
Neural Regen Res; 2015 Feb; 10(2):308-13. PubMed ID: 25883632
[TBL] [Abstract][Full Text] [Related]
2. Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine.
Mazzio E; Soliman KF
Neurotoxicology; 2012 Oct; 33(5):1156-69. PubMed ID: 22776087
[TBL] [Abstract][Full Text] [Related]
3. Regulation of bat echolocation pulse acoustics by striatal dopamine.
Tressler J; Schwartz C; Wellman P; Hughes S; Smotherman M
J Exp Biol; 2011 Oct; 214(Pt 19):3238-47. PubMed ID: 21900471
[TBL] [Abstract][Full Text] [Related]
4. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.
Cui M; Aras R; Christian WV; Rappold PM; Hatwar M; Panza J; Jackson-Lewis V; Javitch JA; Ballatori N; Przedborski S; Tieu K
Proc Natl Acad Sci U S A; 2009 May; 106(19):8043-8. PubMed ID: 19416912
[TBL] [Abstract][Full Text] [Related]
5. Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.
Pattarini R; Rong Y; Qu C; Morgan JI
Neuroscience; 2008 Sep; 155(4):1174-94. PubMed ID: 18675323
[TBL] [Abstract][Full Text] [Related]
6. Na(+)/H(+) exchanger inhibition modifies dopamine neurotransmission during normal and metabolic stress conditions.
Rocha MA; Crockett DP; Wong LY; Richardson JR; Sonsalla PK
J Neurochem; 2008 Jul; 106(1):231-43. PubMed ID: 18363831
[TBL] [Abstract][Full Text] [Related]
7. Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: a proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGE.
Kultima K; Scholz B; Alm H; Sköld K; Svensson M; Crossman AR; Bezard E; Andrén PE; Lönnstedt I
BMC Bioinformatics; 2006 Oct; 7():475. PubMed ID: 17067368
[TBL] [Abstract][Full Text] [Related]
8. Strategies for the protection of dopaminergic neurons against neurotoxicity.
Gerlach M; Double KL; Youdim MB; Riederer P
Neurotox Res; 2000; 2(2-3):99-114. PubMed ID: 16787835
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and MPP+-induced hydroxyl radical generation.
Obata T
J Neural Transm (Vienna); 2006 Sep; 113(9):1131-44. PubMed ID: 16463115
[TBL] [Abstract][Full Text] [Related]
10. Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.
Dauer W; Kholodilov N; Vila M; Trillat AC; Goodchild R; Larsen KE; Staal R; Tieu K; Schmitz Y; Yuan CA; Rocha M; Jackson-Lewis V; Hersch S; Sulzer D; Przedborski S; Burke R; Hen R
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14524-9. PubMed ID: 12376616
[TBL] [Abstract][Full Text] [Related]
11. Environmental estrogen-like chemicals and hydroxyl radicals induced by MPTP in the striatum: a review.
Obata T
Neurochem Res; 2002 May; 27(5):423-31. PubMed ID: 12064359
[TBL] [Abstract][Full Text] [Related]
12. Intrastriatal grafts of fetal mesencephalic cell suspensions in MPP+-lesioned rats: a microdialysis study in vivo.
Espejo M; Ambrosio S; Llorens J; Cutillas B
Neurochem Res; 1998 Oct; 23(10):1217-23. PubMed ID: 9804276
[TBL] [Abstract][Full Text] [Related]
13. Striatal and urinary DOPAC/DA ratio may indicate a long-lasting DA release enhancement by MPP+ and MPTP.
Bagchi SP
Neurochem Res; 1998 Feb; 23(2):127-34. PubMed ID: 9475505
[TBL] [Abstract][Full Text] [Related]
14. The tyramine binding site in the central nervous system: an overview.
Vaccari A
Neurochem Res; 1993 Aug; 18(8):861-8. PubMed ID: 8396735
[TBL] [Abstract][Full Text] [Related]
15. The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates.
Lange KW; Löschmann PA; Sofic E; Burg M; Horowski R; Kalveram KT; Wachtel H; Riederer P
Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):586-92. PubMed ID: 7907775
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
17. Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine.
Vaccari A; Del Zompo M; Melis F; Gessa GL; Rossetti ZL
Br J Pharmacol; 1991 Nov; 104(3):573-4. PubMed ID: 1797320
[TBL] [Abstract][Full Text] [Related]
18. In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+.
Obata T; Chiueh CC
J Neural Transm Gen Sect; 1992; 89(1-2):139-45. PubMed ID: 1329855
[TBL] [Abstract][Full Text] [Related]
19. MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis.
Rollema H; Kuhr WG; Kranenborg G; De Vries J; Van den Berg C
J Pharmacol Exp Ther; 1988 Jun; 245(3):858-66. PubMed ID: 2455037
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
